
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About


Afya Ltd (AFYA)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: AFYA (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $19.4
1 Year Target Price $19.4
1 | Strong Buy |
2 | Buy |
2 | Hold |
1 | Sell |
3 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -40.99% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.42B USD | Price to earnings Ratio 11.14 | 1Y Target Price 19.4 |
Price to earnings Ratio 11.14 | 1Y Target Price 19.4 | ||
Volume (30-day avg) 9 | Beta 0.57 | 52 Weeks Range 13.47 - 19.90 | Updated Date 09/15/2025 |
52 Weeks Range 13.47 - 19.90 | Updated Date 09/15/2025 | ||
Dividends yield (FY) 1.49% | Basic EPS (TTM) 1.4 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 19.58% | Operating Margin (TTM) 31.02% |
Management Effectiveness
Return on Assets (TTM) 8.42% | Return on Equity (TTM) 16.45% |
Valuation
Trailing PE 11.14 | Forward PE 8.1 | Enterprise Value 1810989086 | Price to Sales(TTM) 0.4 |
Enterprise Value 1810989086 | Price to Sales(TTM) 0.4 | ||
Enterprise Value to Revenue 2.75 | Enterprise Value to EBITDA 6.29 | Shares Outstanding 47008300 | Shares Floating 8007715 |
Shares Outstanding 47008300 | Shares Floating 8007715 | ||
Percent Insiders 68.11 | Percent Institutions 19.48 |
Upturn AI SWOT
Afya Ltd

Company Overview
History and Background
Afya Ltd. was founded in 2019, through the combination of NRE Educacional S.A. and Medcel, both focused on medical education. It has grown through acquisitions and organic expansion to become a leading medical education group in Brazil.
Core Business Areas
- Undergraduate Medical Education: Offers undergraduate medical degree programs across various campuses in Brazil.
- Continuing Medical Education: Provides continuing medical education courses and resources for practicing physicians.
- Digital Health Services: Operates digital health platforms and services connecting doctors and patients.
Leadership and Structure
Afya's leadership team consists of experienced professionals in education, healthcare, and technology. The organizational structure is designed to support decentralized operations while maintaining central oversight and strategic direction. Renato Diniz is currently the CEO.
Top Products and Market Share
Key Offerings
- Undergraduate Medical Degree Programs: Core offering generating significant revenue. It has high growth rates based on the current need for doctors in Brazil. Competitors include other Brazilian medical schools such as Estu00e1cio and UNIP.
- Medcel: Medcel offers preparatory courses for medical residency exams. Competitors include Sanar and other smaller prep course providers. Specific market share data not readily available but is a leading provider in Brazil.
- Pequeno Mu00e9dico: Pequeno Mu00e9dico is a platform to assist medical education. The number of users and revenue are not explicitly stated. Competitors include Whitebook.
Market Dynamics
Industry Overview
The Brazilian medical education market is growing due to a shortage of doctors and increasing demand for quality healthcare services. Government regulations and accreditation processes play a significant role in the industry.
Positioning
Afya is a leading player in the Brazilian medical education market, distinguished by its scale, comprehensive offerings, and digital capabilities. Their competitive advantages include a strong brand, a large student base, and a focus on innovation.
Total Addressable Market (TAM)
The TAM for medical education in Brazil is estimated in the billions of USD. Afya is well-positioned to capture a significant portion of this market through organic growth and acquisitions.
Upturn SWOT Analysis
Strengths
- Leading market position in Brazilian medical education
- Comprehensive range of medical education programs
- Strong brand recognition
- Focus on innovation and digital solutions
- Experienced management team
Weaknesses
- Exposure to regulatory changes in Brazil
- Dependence on Brazilian economy
- Competition from other medical education providers
- Currency risk (BRL/USD)
Opportunities
- Expanding into new geographic regions within Brazil
- Acquiring complementary businesses
- Developing new digital health services
- Increasing online learning offerings
- Partnerships with hospitals and healthcare providers
Threats
- Increased competition from existing and new players
- Changes in government regulations impacting medical education
- Economic downturn in Brazil
- Fluctuations in currency exchange rates
Competitors and Market Share
Key Competitors
- YDUQS (YDUQ3.SA)
- Cogna Educau00e7u00e3o (COGN3.SA)
Competitive Landscape
Afyau2019s competitive advantages include a focus on medical education, strong brand, and digital capabilities. Disadvantages include exposure to the Brazilian economy and regulatory environment.
Major Acquisitions
IPEduc
- Year: 2020
- Acquisition Price (USD millions): 25
- Strategic Rationale: Expanding the company's presence in specific medical specializations.
Growth Trajectory and Initiatives
Historical Growth: Afya has experienced rapid growth through acquisitions and organic expansion, capitalizing on the demand for medical education in Brazil.
Future Projections: Analyst projections often forecast continued revenue growth and profitability improvements driven by increasing enrollment and expansion into new markets.
Recent Initiatives: Recent initiatives include strategic acquisitions of medical schools and digital health companies, as well as the launch of new online learning programs.
Summary
Afya Ltd is a leading medical education group in Brazil with a strong position in a growing market. The company's focus on innovation and digital solutions, as well as its strategic acquisitions, has fueled its growth. Key challenges include exposure to the Brazilian economy and regulatory changes, which must be considered. However, overall Afya is a strong player in this education market.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Analyst Reports
- Market Research Reports
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It should not be considered financial advice. Market share data is approximate. Investment decisions should be based on thorough research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Afya Ltd
Exchange NASDAQ | Headquaters Nova Lima, MG, Brazil | ||
IPO Launch date 2019-07-19 | CEO - | ||
Sector Consumer Defensive | Industry Education & Training Services | Full time employees - | Website https://www.afya.com.br |
Full time employees - | Website https://www.afya.com.br |
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. In addition, it offers printed and digital content, as well as an online medical education platform and practical medical training services. Further, the company offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics, and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. Afya Limited was founded in 1999 and is headquartered in Nova Lima, Brazil.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.